Estimating the effects of global patent protection in pharmaceuticals: A case study of quinolones in India

被引:109
作者
Chaudhuri, Shubham
Goldberg, Pinelopi K.
Jia, Panle
机构
[1] World Bank, Washington, DC 20433 USA
[2] Yale Univ, Dept Econ, New Haven, CT 06520 USA
[3] Natl Bur Econ Res, Cambridge, MA 02138 USA
[4] MIT, Dept Econ, Cambridge, MA 02142 USA
关键词
D O I
10.1257/aer.96.5.1477
中图分类号
F [经济];
学科分类号
02 ;
摘要
Under the Agreement on Trade-Related Intellectual Property Rights, the World Trade Organization members are required to enforce product patents for pharmaceuticals. In this paper we empirically investigate the welfare effects of this requirement on developing countries using data for the fuoroquinolones subsegment of the systemic anti-bacterials segment of the Indian pharmaceuticals market. Our results suggest that concerns about the potential adverse welfare effects of TRIPS may have some basis. We estimate that the withdrawal of all domestic products in this subsegment is associated with substantial welfare losses to the Indian economy, even in the presence of price regulation. The overwhelming portion of this welfare loss derives from the loss of consumer welfare.
引用
收藏
页码:1477 / 1514
页数:38
相关论文
共 48 条
[41]   A new global effort to control malaria [J].
Sachs, JD .
SCIENCE, 2002, 298 (5591) :122-124
[42]   Post-TRIPS options for access to patented medicines in developing nations [J].
Scherer, FM ;
Watal, J .
JOURNAL OF INTERNATIONAL ECONOMIC LAW, 2002, 5 (04) :913-939
[43]  
STEVENSON RW, 2001, NY TIMES 1115
[44]  
SUBRAMANIAN A, 1995, INT J TECHNOL MANAGE, V10, P252
[46]   Pharmaceutical patents, prices and welfare losses: Policy options for India under the WTO TRIPS agreement [J].
Watal, J .
WORLD ECONOMY, 2000, 23 (05) :733-752
[47]  
WATTAL J, 1996, WORLD COMPETITION, V20, P5
[48]  
WRIGHT BD, 1983, AM ECON REV, V73, P691